Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Enamine Derivative. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114276286A reveals a novel one-pot synthesis of N,N-disubstituted-alpha,beta-unsaturated enamines using DMSO and base, offering significant cost reduction in API manufacturing.
Novel iodine-catalyzed oxidative sulfonylation method for high-purity pharmaceutical intermediates with reduced costs and scalable production capabilities.
Novel Ru/Ni dual-catalyzed method for cyano-enamines offers mild conditions and high selectivity, optimizing pharmaceutical intermediate supply chains.
Patent CN109232284B reveals a novel acid-catalyzed route for polysubstituted enamine aldehydes, offering high yields and simplified purification for pharmaceutical manufacturing.
Patent CN115304557B reveals cost-effective manganese catalysis for enamine derivatives, offering supply chain stability and reduced manufacturing costs for pharmaceutical intermediates.
Patent CN115925692A details a robust Rh(III)-catalyzed route for trifluoromethyl enamines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115304557B details manganese-catalyzed enamine synthesis offering cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN115925692A details Rh-catalyzed C-H activation for trifluoromethyl enamines. High yields, scalable process for drug discovery.
Patent CN115925692A details a robust Rh-catalyzed route for trifluoromethyl enamines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Patent CN115304557B reveals low-cost manganese catalysis for enamine synthesis, offering high yield and scalable pharmaceutical intermediate manufacturing solutions.